The Best 3 Consumer Staples Stocks to Buy and Hold for Decades

The article highlights three consumer-staples-like stocks that have fallen 48% to 56% from 52-week highs but are argued to have durable long-term upside: Chewy, Stride, and Sprouts Farmers Market. Chewy is cited as 56% below its high despite revenue up 8%, free cash flow up 24%, and 84% of revenue coming from recurring Autoship sales, while Stride is down 48% after enrollment disruptions but is back to 2% enrollment growth and targets 10% annual revenue growth through 2028. Sprouts is 52% below its high after a valuation reset, yet sales still rose 4% and the company is expanding toward a long-term 1,400-store goal.

Analysis

The setup here is less about “cheap staples” and more about forced de-rating after execution noise. Each name has a different recovery path: CHWY is a recurring-revenue compounder with improving mix, LRN is a post-misstep reversion story with operating leverage, and SFM is the highest-quality asset but most exposed to multiple compression because the market previously priced it like a flawless growth concept. The common thread is that all three are now trading closer to “prove-it” valuations, which usually creates a better entry point for patient capital than when the narrative is clean.

The second-order effect is that the market may be underestimating how defensive these business models are versus their volatility suggests. In CHWY, subscription/auto-replenishment behavior can cushion demand even if discretionary pet spend weakens; in SFM, premium grocery tends to win share when households trade down from restaurants and branded center-store items; in LRN, regulatory barriers and school-district inertia create a slow-moving customer base that is harder to disrupt than headline tech risk implies. The real competitive risk is not a recession, but peers copying the profitable parts: grocers can imitate private label, education platforms can narrow feature gaps, and pet retailers can compete on price and fulfillment, which caps long-term margin expansion if execution slips.

The contrarian view is that the drawdowns may be only partially about fundamentals and more about prior ownership crowding and multiple reset. If earnings simply track guidance, these names likely rerate over 6-12 months as the market stops paying a penalty for recent disappointment. The tail risk is that each company is now priced for “good enough,” so any re-acceleration disappointment or operational stumble could keep them range-bound despite cheap-looking forward multiples.

Key Decisions for Investors

• Go long CHWY on weakness for a 6-9 month trade; best risk/reward is if autoship retention stays high and margin mix continues to improve. Treat 13x forward earnings as a floor only if FCF conversion remains above peer retail levels.
• Buy LRN as a mean-reversion recovery name over the next 2-4 quarters; the catalyst is continued enrollment normalization and proof that the platform upgrade issue was a one-off. Risk is that one more operational miss permanently lowers its growth multiple.
• Accumulate SFM selectively rather than chase; use a staggered entry over 30-60 days because the stock’s prior valuation was the primary issue, not the business. Upside is a rerate toward a premium grocer multiple if unit growth stays visible.
• Pair long SFM / short a lower-quality conventional grocer basket if you can source it; the thesis is that attribute-based pricing power and private-label optionality should outperform a slower, more commoditized food retail cohort over 12 months.
• For options, prefer long-dated call spreads in CHWY or LRN instead of outright stock if you want convexity with defined downside; these names can be volatile, but the payoff improves if the market re-rates them before the fundamentals fully inflect.